The guidance on developing the joint forward plan supports integrated care boards, their partner NHS trusts and foundation trusts to continue to develop their joint forward plans with system partners.
18hon MSN
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback